Former general counsel of Novo Nordisk joins Lowenstein Sandler

Law firm Lowenstein Sandler announced that James Shehan, former general counsel of Novo Nordisk, will join the firm as a senior counsel in its life sciences practice and as head of the firm’s FDA regulatory practice.

WELCOME TO OUR OPEN HOUSE – LOG IN TO CONTINUE READING FOR FREE

If you are already a registered user or a member, SIGN IN now.